1. Home
  2. KALV

as 10-20-2025 9:37am EST

$
-
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Stocks

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

KalVista Pharmaceuticals Inc is a pharmaceutical company developing and delivering oral therapies for individuals affected by rare diseases with unmet needs. The company applies its knowledge in the kallikrein-kinin system (KKS) and oral drug discovery to develop small-molecule protease inhibitor medicines to address the needs of patients with diseases driven by plasma kallikrein and Factor XIIa. Its FDA-approved product EKTERLY (sebetralstat) is a novel, orally delivered, small-molecule plasma kallikrein inhibitor for the treatment of acute attacks of hereditary angioedema (HAE) in adult and pediatric patients aged twelve years and older.

Founded: N/A Country:
United States
United States
Employees: N/A City: CAMBRIDGE
Market Cap: 796.4M IPO Year: N/A
Target Price: $26.43 AVG Volume (30 days): 1.5M
Analyst Decision: Strong Buy Number of Analysts: 8
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -3.95 EPS Growth: N/A
52 Week Low/High: $7.30 - $17.28 Next Earning Date: 12-04-2025
Revenue: $1,426,000 Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): 209.38%

Stock Insider Trading Activity of KalVista Pharmaceuticals Inc. (KALV)

Name Ticker Relationship Date Transaction AVG Cost Per Share Shares Total Value Securities Owned After Transaction(s) SEC Form 4
Palleiko Benjamin L KALV CHIEF EXECUTIVE OFFICER Sep 8 '25 Sell $15.84 7,294 $115,536.96 395,189
Yea Christopher KALV CHIEF DEVELOPMENT OFFICER Aug 25 '25 Sell $13.42 1,954 $26,222.68 132,052
Audhya Paul K. KALV CHIEF MEDICAL OFFICER Aug 25 '25 Sell $13.42 2,336 $31,349.12 122,505
Sweeny Nicole KALV Chief Commercial Officer Aug 25 '25 Sell $13.42 1,480 $19,861.60 32,291
Palleiko Benjamin L KALV CHIEF EXECUTIVE OFFICER Aug 22 '25 Sell $13.22 10,940 $144,657.43 395,189
Yea Christopher KALV CHIEF DEVELOPMENT OFFICER Aug 22 '25 Sell $13.22 2,362 $31,232.25 132,052
Audhya Paul K. KALV CHIEF MEDICAL OFFICER Aug 22 '25 Sell $13.22 2,942 $38,901.48 122,505
Sweeny Nicole KALV Chief Commercial Officer Aug 22 '25 Sell $13.22 1,864 $24,647.30 32,291
Palleiko Benjamin L KALV CHIEF EXECUTIVE OFFICER Aug 18 '25 Sell $13.19 4,409 $58,141.48 395,189
Yea Christopher KALV CHIEF DEVELOPMENT OFFICER Aug 18 '25 Sell $13.19 2,649 $34,932.36 132,052

Share on Social Networks: